Literature DB >> 28422902

Evaluation of the Osteoinductive Effect of PDGF-BB Associated With Different Carriers in Bone Regeneration in Bone Surgical Defects in Rats.

Júlio César Silva de Oliveira1, Roberta Okamoto, Celso Koogi Sonoda, Wilson Roberto Poi, Idelmo Rangel Garcia Júnior, Eloá Rodrigues Luvizuto.   

Abstract

PURPOSE: Extensive bone defects in maxillofacial region can be corrected with autograft. However the disadvantages of this type of therapy lead to the search for new bone substitutes. Thus, we evaluated the biological behavior and osteoinductive platelet-derived growth factor type BB (PDGF-BB) associated with different carriers, by histological analysis and immunohistochemical histometric critical defects performed in rat calvaria.
MATERIALS AND METHODS: Critical defects were created with 5-mm diameter calvaria of rats. Each defect was randomly divided into 8 experimental groups, evaluated at 15 and 30 postoperative days for histomorphometry and immunohistochemistry.
RESULTS: The results showed new bone formation in all groups, independent of postoperative time. At 30 days, the beta-tricalcium phosphate matrix (TCP) group just did not differ from bone matrix mineralized bovine (BIO) group in the new bone formation (P = 0.1403). In none of the groups' analyzed biomaterials, growth factor stimulated increase in bone formation (P > 0.05).
CONCLUSION: With the methodology used, the growth factor associated with the tested biomaterials did not induce new bone formation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28422902     DOI: 10.1097/ID.0000000000000580

Source DB:  PubMed          Journal:  Implant Dent        ISSN: 1056-6163            Impact factor:   2.454


  1 in total

1.  Potential Use of 3D CORAGRAF-Loaded PDGF-BB in PLGA Microsphere Seeded Mesenchymal Stromal Cells in Enhancing the Repair of Calvaria Critical-Size Bone Defect in Rat Model.

Authors:  Saktiswaren Mohan; Puvanan Karunanithi; Malliga Raman Murali; Khairul Anwar Ayob; Jayaraman Megala; Krishnamurithy Genasan; Tunku Kamarul; Hanumantha Rao Balaji Raghavendran
Journal:  Mar Drugs       Date:  2022-08-31       Impact factor: 6.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.